Pigmented Neurodevelopmental Disorders: Giant Congenital Nevi and Neurocutaneous Melanocytosis
Objectives and Disclosures
Participants will be able to:
- Differentiate between proliferative nodules, so-called "melanoma" in CMN, and neurocutaneous melanocytosis.
- Evaluate the symptoms associated with congenital melanocytic nevi in relationship to their cellular components and sites of involvement.
- Compare prenatal with postnatal nevi, including their genetic and histological differences.
Planners disclose they have no relevant financial relationships.
Speaker discloses: Expert Editor and Author, WHO Classification of Paediatric Tumours; IARC; PAED5; CNS5; Urinary and Male Genital Tumours; Genetic Tumour Syndromes.
All relevant financial relationships have been mitigated.
Miguel Reyes-Múgica, MD
Marjory K. Harmer Chair in Pediatric Pathology, Chief of Pathology and Head of Laboratories, UPMC Children’s Hospital of Pittsburgh; Professor of Pathology, University of Pittsburgh
Seattle Children’s is accredited by the Washington State Medical Association CME Accreditation Committee to sponsor continuing medical education for physicians.
Seattle Children’s designates this online educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This activity meets the criteria for up to 1 hour of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
Videos are available for only one year after posting.
If you wish to receive Category I CME credit for viewing this Provider Grand Rounds session, please complete the evaluation form. Upon completion of the form you will receive an auto-reply email that will serve as the only confirmation of your CME credit. Please keep the email for your records.